We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Top Buys

Rank Stock Value
1
TLOG
TetraLogic Pharmaceuticals Corporation
TLOG
+$8.36M
2
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$8.14M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$5.91M
4
KMB icon
Kimberly-Clark
KMB
+$5.03M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$3.89M

Top Sells

Rank Stock Value
1
ELD icon
WisdomTree Emerging Markets Local Debt Fund
ELD
+$5.52M
2
BKLN icon
Invesco Senior Loan ETF
BKLN
+$5.39M
3
IXG icon
iShares Global Financials ETF
IXG
+$5.36M
4
CVE icon
Cenovus Energy
CVE
+$5.09M
5
EPP icon
iShares MSCI Pacific ex Japan ETF
EPP
+$4.89M

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
1151
BioMarin Pharmaceuticals
BMRN
$12.8B
$226K 0.01%
+3,216
New +$218K
FDUS icon
1152
Fidus Investment
FDUS
$748M
$226K 0.01%
10,400
-5,700
-35% -$116K
RYL
1153
DELISTED
RYLAND GROUP INC
RYL
$226K 0.01%
5,203
+96
+2% +$3.81K
MCP.PRA
1154
DELISTED
MOLYCORP, INC PFD CONV SER A
MCP.PRA
$226K 0.01%
18,500
-2,100
-10% -$33.7K
DES icon
1155
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$225K 0.01%
+9,954
New +$217K
PLD icon
1156
Prologis
PLD
$131B
$225K 0.01%
+6,097
New +$235K
PBE icon
1157
Invesco Biotechnology & Genome ETF
PBE
$357M
$224K 0.01%
+6,047
New +$217K
XPH icon
1158
State Street SPDR S&P Pharmaceuticals ETF
XPH
$509M
$224K 0.01%
+5,082
New +$212K
WMGI
1159
DELISTED
Wright Medical Group Inc
WMGI
$224K 0.01%
+7,300
New +$207K
CCX
1160
DELISTED
WISDOMTREE COMMODITY CURRENCY STRATEGY FUND
CCX
$224K 0.01%
11,240
-478
-4% -$9.66K
JNY
1161
DELISTED
JONES GROUP INC COM STK (PA)
JNY
$224K 0.01%
+15,000
New +$217K
BYM
1162
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$223K 0.01%
+17,564
New +$226K
IHG icon
1163
InterContinental Hotels
IHG
$23B
$223K 0.01%
+4,669
New +$203K
NUS icon
1164
Nu Skin
NUS
$255M
$223K 0.01%
+1,610
New +$190K
PODD icon
1165
Insulet
PODD
$9.91B
$223K 0.01%
+6,000
New +$222K
SPHB icon
1166
Invesco S&P 500 High Beta ETF
SPHB
$931M
$223K 0.01%
+7,280
New +$210K
TAP icon
1167
Molson Coors Class B
TAP
$7.88B
$223K 0.01%
3,966
-4,653
-54% -$249K
ASP
1168
DELISTED
AMERN STRATEGIC INCOME PORTFOL
ASP
$223K 0.01%
24,900
+5,200
+26% +$50.1K
MMD
1169
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$281M
$222K 0.01%
+14,056
New +$220K
SMH icon
1170
VanEck Semiconductor ETF
SMH
$71.1B
$222K 0.01%
+10,486
New +$215K
ALLT icon
1171
Allot
ALLT
$380M
$221K 0.01%
+14,643
New +$199K
GMLP
1172
DELISTED
Golar LNG Partners LP
GMLP
$220K 0.01%
7,275
-550
-7% -$17K
JTP
1173
DELISTED
NUVEEN QUALITY PFD INCOME FD
JTP
$220K 0.01%
28,604
+770
+3% +$5.86K
LYB icon
1174
LyondellBasell Industries
LYB
$20B
$218K 0.01%
+2,721
New +$209K
SLAB icon
1175
Silicon Laboratories
SLAB
$7.2B
$217K 0.01%
5,000
– –
45 46
47
48 49

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.